Contact:
VP
Investor Relations
T: +61 419 548 434
E: lisa.pendlebury@maynepharma.com
About
(C) 2021 Electronic News Publishing, source
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
7.03 AUD | -1.13% | -1.26% | +14.31% |
02-26 | Mayne Pharma Group Swings to Loss in Fiscal H1 Despite Revenue Growth; Shares Jump 15% | MT |
02-25 | Transcript : Mayne Pharma Group Limited, H1 2024 Earnings Call, Feb 26, 2024 |
Contact:
VP
Investor Relations
T: +61 419 548 434
E: lisa.pendlebury@maynepharma.com
About
(C) 2021 Electronic News Publishing, source
1st Jan change | Capi. | |
---|---|---|
+14.31% | 378M | |
+20.53% | 43.75B | |
+23.96% | 22.06B | |
+13.30% | 14.46B | |
+13.21% | 13.62B | |
+39.02% | 11.61B | |
-9.66% | 6.9B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+9.64% | 5.32B |